WHAT IS THE FREQUENCY OF POLYPHARMACY IN CLINICAL PRACTICE?
Obviously, patients receiving monodrug therapy cannot experience a drug-drug interaction. Conversely, being on more than one medication does not mean that patients will necessarily experience a drug-drug interaction, but they are at potential risk. Moreover, the more medications a patient is taking, the greater likelihood that he or she will experience such an interaction. To evaluate the extent of this problem, we need to know the percentage of patients in clinical practice taking more than one medication at the same time. To answer this question, my colleagues (Cheryl Carmichael, Anne Harvey, Ph.D., and Dale Horst, Ph.D.) and I surveyed different practice settings to determine the incidence and nature of polypharmacy in different types of clinical practice. To date, we have surveyed four types of clinical practice: primary care; general psychiatric outpatient care; outpatient and inpatient care at a university affiliated Veterans Administration Medical Center; and care of HIV-positiv
Related Questions
- how will results influence clinical practice in the management of symptomatic and asymptomatic extracranial carotid occlusive disease?
- How much does related clinical practice experience count for admission and what are some examples of these experiences?
- WHAT IS THE FREQUENCY OF POLYPHARMACY IN CLINICAL PRACTICE?
